Suppr超能文献

炎症标志物与卒中后不良预后:一项前瞻性队列研究和白细胞介素-6 的系统评价。

Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6.

机构信息

Division of Clinical Neurosciences, Western General Hospital, University of Edinburgh, Edinburgh, United Kingdom.

出版信息

PLoS Med. 2009 Sep;6(9):e1000145. doi: 10.1371/journal.pmed.1000145. Epub 2009 Sep 8.

Abstract

BACKGROUND

The objective of this study was to determine whether: (a) markers of acute inflammation (white cell count, glucose, interleukin-6, C-reactive protein, and fibrinogen) are associated with poor outcome after stroke and (b) the addition of markers to previously validated prognostic models improves prediction of poor outcome.

METHODS AND FINDINGS

We prospectively recruited patients between 2002 and 2005. Clinicians assessed patients and drew blood for inflammatory markers. Patients were followed up by postal questionnaire for poor outcome (a score of>2 on the modified Rankin Scale) and death through the General Register Office (Scotland) at 6 mo. We performed a systematic review of the literature and meta-analysis of the association between interleukin-6 and poor outcome after stroke to place our study in the context of previous research. We recruited 844 patients; mortality data were available in 844 (100%) and functional outcome in 750 (89%). After appropriate adjustment, the odds ratios for the association of markers and poor outcome (comparing the upper and the lower third) were interleukin-6, 3.1 (95% CI: 1.9-5.0); C-reactive protein, 1.9 (95% CI: 1.2-3.1); fibrinogen, 1.5 (95% CI: 1.0-2.36); white cell count, 2.1 (95% CI: 1.3-3.4); and glucose 1.3 (95% CI: 0.8-2.1). The results for interleukin-6 were similar to other studies. However, the addition of inflammatory marker levels to validated prognostic models did not materially improve model discrimination, calibration, or reclassification for prediction of poor outcome after stroke.

CONCLUSIONS

Raised levels of markers of the acute inflammatory response after stroke are associated with poor outcomes. However, the addition of these markers to a previously validated stroke prognostic model did not improve the prediction of poor outcome. Whether inflammatory markers are useful in prediction of recurrent stroke or other vascular events is a separate question, which requires further study. Please see later in the article for the Editors' Summary.

摘要

背景

本研究旨在确定:(a) 急性炎症标志物(白细胞计数、血糖、白细胞介素-6、C 反应蛋白和纤维蛋白原)是否与卒中后不良预后相关;以及 (b) 将标志物添加到先前验证的预后模型中是否能提高不良预后的预测能力。

方法和发现

我们于 2002 年至 2005 年期间前瞻性招募患者。临床医生对患者进行评估并采集血液以检测炎症标志物。通过苏格兰通用登记册(General Register Office,Scotland)以邮寄问卷的形式在 6 个月时对患者进行预后不良(改良 Rankin 量表评分>2)和死亡情况的随访。我们对相关文献进行了系统评价和荟萃分析,以评估白细胞介素-6 与卒中后不良预后之间的关系,从而将我们的研究置于以往研究的背景下。我们共招募了 844 例患者,其中 844 例(100%)患者的死亡率数据和 750 例(89%)患者的功能结局数据可用。在适当调整后,标志物与不良预后(比较上三分之一和下三分之一)的比值比(odds ratio,OR)分别为白细胞介素-6:3.1(95%置信区间:1.9-5.0);C 反应蛋白:1.9(95%置信区间:1.2-3.1);纤维蛋白原:1.5(95%置信区间:1.0-2.36);白细胞计数:2.1(95%置信区间:1.3-3.4);血糖:1.3(95%置信区间:0.8-2.1)。白细胞介素-6 的结果与其他研究相似。然而,将炎症标志物水平添加到先前验证的预后模型中并不能显著提高对卒中后不良预后的预测的区分度、校准度或再分类能力。

结论

卒中后急性炎症反应标志物水平升高与不良预后相关。然而,将这些标志物添加到先前验证的卒中预后模型中并不能改善不良预后的预测。炎症标志物是否有助于预测复发性卒中或其他血管事件是一个单独的问题,需要进一步研究。请参见文章后面的编辑总结。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb2/2730573/7c6da4ece957/pmed.1000145.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验